Details for Patent: 10,537,584

Which drugs does patent 10,537,584 protect, and when does it expire?

Patent 10,537,584 protects MILPROSA and is included in one NDA.

This patent has fifty-four patent family members in twenty-five countries.

Summary for Patent: 10,537,584

Title:	Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
Abstract:	The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
Inventor(s):	Salah U. Ahmed, Jiaxiang Tsao, Anu Mahashabde, Diane D. Harrison
Assignee:	Ferring BV
Application Number:	US15/176,169
Patent Claim Types: see list of patent claims	Use; Compound;

Drugs Protected by US Patent 10,537,584

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ferring Pharms Inc	MILPROSA	progesterone	SYSTEM;VAGINAL	201110-001	Apr 29, 2020		DISCN	Yes	No			Y

International Family Members for US Patent 10,537,584

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	070561
Australia	2009210779
Brazil	PI0905946
Canada	2713943